Immuno-Oncology: Halfway To Adulthood
It Has Been A Tremendous Decade For The Immuno-Oncology Field
Executive Summary
Almost a decade on since the first approval for an immuno-oncology therapy, In Vivo analyzes the current landscape, the evolution of combination cancer treatments that use the immune system to target disease and future commercial potential for the market.